Clicky

Livzon Pharmaceutical Group Inc(1513)

Description: Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for the patients of lung and stomach cancer. It also offers diagnostic reagents, such as diagnostic kit for IgM/IgG antibody to coronavirus; nucleic acid test kit for human immunodeficiency virus type 1; antinuclear antibody test kits; interferon-gamma release assays test kits; and rapid test for mycoplasma pneumoniae IgM antibody. In addition, the company provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. It also exports its products. The company was founded in 1985 and is headquartered in Zhuhai, China.


Keywords: Pharmaceutical Products Immunology Antibiotics Active Pharmaceutical Ingredients Antibody Influenza Schizophrenia Glycoproteins Injection Biochemistry Pharmaceutical Raw Materials Biologic Products Upper Respiratory Tract Infection Vertigo Duodenal Ulcers Tiredness Anovulation Biochemical Drugs Ilaprazole Laprazole Leuprorelin Leuprorelin Acetate Lung And Stomach Cancer Peptic Ulcer Hemorrhage Perospirone Hydrochloride Reflux Esophagitis Urofollitropin

Home Page: www.livzon.com.cn

Headquarters Building
Zhuhai, 519090
China
Phone: 86 75 6813 5888


Officers

Name Title
Mr. Yanggang Tang Pres & Exec. Director
Mr. Guoxiang Xu Exec. Vice Chairman & VP of Sales
Ms. Yanxia Si VP & CFO
Mr. Liang Yang VP & Company Sec.
Jianing Liu Chief Investment Officer & Head of BD Dept.
Ms. Jianying Zhuang Head of Accounting Department
Mr. Maolin Wang Chief Supervisor and GM of Legal & Compliance

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 0
Trailing PE: 12.7523
Price-to-Book MRQ: 1.6145
Price-to-Sales TTM: 2.7252
IPO Date:
Fiscal Year End: December
Full Time Employees: 8580
Back to stocks